Publications by authors named "Martin F Fey"

67Publications

The costs of care in haematological cancers: Health economic issues.

Authors:
Martin F Fey

Hematol Oncol 2017 Jun;35 Suppl 1:15-19

University and Inselspital, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2394DOI Listing
June 2017

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.

Lung Cancer 2017 05 14;107:73-83. Epub 2016 Jun 14.

Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.06.004DOI Listing
May 2017

The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.

Leuk Res 2016 Feb 19;41:96-102. Epub 2015 Dec 19.

Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2015.12.006DOI Listing
February 2016

Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells.

J Leukoc Biol 2015 Sep 19;98(3):357-63. Epub 2015 May 19.

*Division of Experimental Pathology, Institute of Pathology, and Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA; and Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.1AB0514-258RDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541502PMC
September 2015

Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells.

Leuk Res Rep 2015 23;4(1):32-5. Epub 2015 Apr 23.

Division of Experimental Pathology, Institute of Pathology, University of Bern, Switzerland ; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2015.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431638PMC
May 2015

[Today's cancer medicine: less could often be more].

Authors:
Martin F Fey

Ther Umsch 2014 Dec;71(12):765-70

Universitätsklinik für medizinische Onkologie, Universität Bern und Inselspital, Bern.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000623DOI Listing
December 2014

Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation.

Leuk Res 2014 Sep 1;38(9):1041-7. Epub 2014 Jul 1.

Division of Experimental Pathology, Institute of Pathology, University of Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126140018
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2014.06.010DOI Listing
September 2014

CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation.

Sci Rep 2014 Mar 3;4:4261. Epub 2014 Mar 3.

1] Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Bern, Switzerland [2] Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland [3] Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland [4] Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep04261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939455PMC
March 2014

Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology.

Future Oncol 2014 Feb;10(2):211-7

Department of Clinical Research, University of Bern, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.13.179DOI Listing
February 2014

Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation.

Biochem Biophys Res Commun 2013 Aug 24;438(2):283-8. Epub 2013 Jul 24.

Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2013.07.056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225710PMC
August 2013

Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells.

Biochem Biophys Res Commun 2013 Feb 9;431(2):264-9. Epub 2013 Jan 9.

Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2012.12.120DOI Listing
February 2013

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation.

Exp Hematol Oncol 2012 Sep 4;1(1):25. Epub 2012 Sep 4.

Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Murtenstrasse 35, CH-3010, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2162-3619-1-25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514096PMC
September 2012

Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells.

Leuk Res 2012 Dec 13;36(12):1552-6. Epub 2012 Sep 13.

Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.08.024DOI Listing
December 2012

MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.

J Thorac Oncol 2012 Jul;7(7):1069-77

Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31824fe976DOI Listing
July 2012

PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.

Blood 2012 May 12;119(21):4963-70. Epub 2012 Apr 12.

Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-09-378117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367898PMC
May 2012

Marriage risk of cancer research fellows.

Lancet 2011 Dec;378(9809):2070

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)61898-9DOI Listing
December 2011

Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells.

Leuk Res 2012 Feb 16;36(2):237-40. Epub 2011 Nov 16.

Experimental Oncology/Hematology, Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.10.006DOI Listing
February 2012

[Recombinant proteins as therapeutic compounds in clinical oncology].

Authors:
Martin F Fey

Ther Umsch 2011 Nov;68(11):618-30

Universitätsklinik und -Poliklinik für Medizinische Onkologie, Inselspital und Universität Bern.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000222DOI Listing
November 2011

Deregulated expression of Kruppel-like factors in acute myeloid leukemia.

Leuk Res 2011 Jul 5;35(7):909-13. Epub 2011 Apr 5.

Department of Clinicial Research, Experimental Oncology and Hematology, University of Bern, and Department of Hematology, Inselspital, Bern University Hospital, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.03.010DOI Listing
July 2011

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.

Support Care Cancer 2012 Jan 14;20(1):141-7. Epub 2011 Jan 14.

Department of Medical Oncology, University Hospital Bern, 3010, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-010-1079-3DOI Listing
January 2012

Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?

Swiss Med Wkly 2010 1;140:w13106. Epub 2010 Nov 1.

Experimental Oncology/Haematology Experimental Oncology/Haematology, MEM E829, Department of Clinical Research, University of Bern, Murtenstrasse 35, 3010 Bern, CH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2010.13106DOI Listing
February 2011

[Lymphoma--a topic with seven seals].

Authors:
Martin F Fey

Ther Umsch 2010 Oct;67(10):489

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000082DOI Listing
October 2010

[Salient clinical features of lymphoma and related lymphoproliferative disorders].

Authors:
Martin F Fey

Ther Umsch 2010 Oct;67(10):491-5

Universitätsklinik und Poliklinik for Medizinische Onkologie, Inselspital Bern.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/0040-5930/a000083DOI Listing
October 2010

Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.

Br J Haematol 2010 Apr 20;149(1):55-64. Epub 2010 Jan 20.

Department of Clinical Research, Experimental Oncology/Haematology, Bern University Hospital, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.08040.xDOI Listing
April 2010

NDRG1/2 expression is inhibited in primary acute myeloid leukemia.

Leuk Res 2010 Mar 22;34(3):393-8. Epub 2009 Sep 22.

Experimental Oncology/Hematology, Bern University Hospital, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.08.037DOI Listing
March 2010

Tumor suppressor genes in myeloid differentiation and leukemogenesis.

Future Oncol 2009 Mar;5(2):245-57

Department of Medical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.5.2.245DOI Listing
March 2009

HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.

Br J Haematol 2008 Apr 3;141(2):179-87. Epub 2008 Mar 3.

Experimental Oncology/Haematology, Department of Clinical Research, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.06992.xDOI Listing
April 2008

What is the current treatment of PTLD after liver transplantation?

J Hepatol 2006 Jan 7;44(1):23-6. Epub 2005 Nov 7.

Department of Clinical Pharmacology, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2005.10.009DOI Listing
January 2006

Pneumococcal vaccination in splenectomised cancer patients.

Eur J Cancer 2005 Aug;41(12):1731-4

Department of Medical Oncology, University Hospital, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.04.027DOI Listing
August 2005

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Clin Cancer Res 2005 Feb;11(4):1416-24

Institute of Medical Oncology and the Laboratory for Molecular Diagnostics, Department of Hematology, University of Berne, CH-3010 Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1552DOI Listing
February 2005

Clinical trial design in oncology: selection of patients.

Authors:
Martin F Fey

Lancet Oncol 2004 Dec;5(12):760

Institute of Medical Oncology, Inselspital and University, Bern, Switzerland.

View Article

Download full-text PDF

Source
December 2004

P73 status in B-cell chronic lymphocytic leukaemia.

Leuk Lymphoma 2004 Jun;45(6):1205-7

Department of Clinical Research, Medical Oncology/Hematology, University and Inselspital Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10298190310001623829DOI Listing
June 2004

Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL).

Leuk Lymphoma 2004 May;45(5):887-96

Department of Medical Oncology and Haematology, University and Inselspital Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819032000159843DOI Listing
May 2004

Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns.

J Biol Chem 2003 Oct 12;278(44):42750-60. Epub 2003 Aug 12.

Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M307067200DOI Listing
October 2003

Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).

Br J Haematol 2003 Apr;121(1):97-100

Medical Oncology/Haematology, Department of Clinical Research, Inselspital and University of Berne, CH-3010 Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04227.xDOI Listing
April 2003

Impact of the Human Genome Project on the clinical management of sporadic cancers.

Authors:
Martin F Fey

Lancet Oncol 2002 Jun;3(6):349-56

Medical Oncology, Inselspital and University of Berne, Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1470-2045(02)00775-1DOI Listing
June 2002